Track the Nanjing Leads Biolabs Co., Ltd. - B - H Shares stock price and the full directors' dealings record of the company, a publicly traded company based in Hong Kong. Shares are quoted on HK HK, under the authority of HKEX. Market capitalisation: €2.1bn. The latest transaction was reported on 3 July 2026 (Purchase). Among the most active insiders: ZUO HONGGANG. Every trade is accessible without an account.
8
Insider Decl.
n/a
Thresholds
n/a
4 ops.
Buy Volume
n/a
4 ops.
Sell Volume
11Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 25,961 of 26,550 companies
10.3
score / 100
Value
13
Quality
8
FCF yld-6.4%
Earn yld-16%
EV/EBITDA40.3x
ROE-18%
Gross mgn4.8%
Net mgn-12%
Debt/EBITDA24.9x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
About Nanjing Leads Biolabs Co., Ltd. - B - H Shares
Nanjing Leads Biolabs Co., Ltd. is a company focused on the development of biopharmaceutical products. It specializes in research and production of innovative solutions for the healthcare sector.